During the past decade, Fakultni Nemocnice Kralovske Vinohrady conducted 135 clinical trials. In the 10-year time frame, 135 clinical trials started and 63 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 44 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni Nemocnice Kralovske Vinohrady" #1 sponsor was "Bayer" with 10 trials, followed by "Charles University, Czech Republic" with 10 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 118 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni Nemocnice Kralovske Vinohrady" #1 collaborator was "Faculty Hospital Kralovske Vinohrady" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni Nemocnice Kralovske Vinohrady" are "Psoriasis" (8 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Multiple Myeloma" (7 trials), "Crohn Disease" (5 trials) and "Leukemia, Myeloid, Acute" (4 trials). Many other conditions were trialed in "Fakultni Nemocnice Kralovske Vinohrady" in a lesser frequency.

Most popular intervention types in "Fakultni Nemocnice Kralovske Vinohrady" are "Drug" (148 trials), "Other" (17 trials), "Biological" (12 trials), "Device" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Rituximab" (14 trials), "Bendamustine" (5 trials), "Lenalidomide" (5 trials) and "brentuximab vedotin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni Nemocnice Kralovske Vinohrady" are 163 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 73 active trials in "Fakultni Nemocnice Kralovske Vinohrady". 2 are not yet recruiting, 42 are recruiting, 26 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 74 completed trials in Fakultni Nemocnice Kralovske Vinohrady, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni Nemocnice Kralovske Vinohrady, 7 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 107 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 8 trials that are defined as “Not Applicable".

Fakultni Nemocnice Kralovske Vinohrady has several departments that took part in Clinical trials: "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika" - 5 trials